Comparative analysis of aqueous humor cytokine levels between patients with exudative age-related macular degeneration and normal controls

Investigative Ophthalmology and Visual Science

Volumn 54, Issue 10, 2013, Pages 7038-7044

  Cha, Dong Min ^a,b   Woo, Se Joon ^a   Kim, Hye Jung ^c,d   Lee, Cheolju ^c,e   Park, Kyu Hyung ^a  

^a Seoul National University Bundang Hospital   (South Korea)

^b Jeju National University School of Medicine   (South Korea)

^c Korea Institute of Science and Technology   (South Korea)

^d VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e University of Science and Technology (UST)   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

APRIL PROTEIN; CHEMOKINE RECEPTOR CCR7; CHEMOKINE RECEPTOR CCR8; CHEMOKINE RECEPTOR CCR9; CHEMOKINE RECEPTOR CXCR1; CHEMOKINE RECEPTOR CXCR2; CXCL14 CHEMOKINE; CYTOKINE; EOTAXIN 3; GLUCOCORTICOID INDUCED TUMOR NECROSIS FACTOR RECEPTOR; INTERLEUKIN 4 RECEPTOR; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; OSTEONECTIN; SOMATOMEDIN BINDING PROTEIN 2; SOMATOMEDIN BINDING PROTEIN 6; SOMATOMEDIN C; THROMBOSPONDIN; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2; VASCULOTROPIN; BIOLOGICAL MARKER; SOMATOMEDIN;

AGE RELATED MACULAR DEGENERATION; AGED; AQUEOUS HUMOR; ARTICLE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; CHEMISTRY; MACULAR DEGENERATION; METABOLISM; RETROSPECTIVE STUDY; EXUDATIVE AGE-RELATED MACULAR DEGENERATION; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN-2; RAYBIO; RETINA MACULA DEGENERATION;

AGED; AQUEOUS HUMOR; BIOLOGICAL MARKERS; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MACULAR DEGENERATION; MALE; RETROSPECTIVE STUDIES;

AQUEOUS HUMOR; EXUDATIVE AGE-RELATED MACULAR DEGENERATION; INSULIN-LIKE GROWTH FACTOR; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN-2; RAYBIO; VASCULAR ENDOTHELIAL GROWTH FACTOR;

EID: 84891552261     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.13-12730     Document Type: Article

References (42)

1. Matsuoka M, Ogata N, Otsuji T, Nishimura T, Takahashi K, Matsumura M. Expression of pigment epithelium derived factor and vascular endothelial growth factor in choroidal neovascular membranes and polypoidal choroidal vasculopathy. Br J Ophthalmol. 2004;88:809–815.
2. Brown DM, Kaiser PK, Michels M, et al. Ranibizumab versus verteporfin for neovascular age-related macular degeneration. N Engl J Med. 2006;355:1432–1444.
3. Rosenfeld PJ, Brown DM, Heier JS, et al. Ranibizumab for neovascular age-related macular degeneration. N Engl J Med. 2006;355:1419–1431.
4. Kvanta A, Algvere PV, Berglin L, Seregard S. Subfoveal fibrovascular membranes in age-related macular degeneration express vascular endothelial growth factor. Invest Ophthalmol Vis Sci. 1996;37:1929–1934.
5. Miao H, Tao Y, Li XX. Inflammatory cytokines in aqueous humor of patients with choroidal neovascularization. Mol Vis. 2012;18:574–580.
6. Jonas JB, Tao Y, Neumaier M, Findeisen P. Cytokine concentration in aqueous humour of eyes with exudative age-related macular degeneration. Acta Ophthalmol. 2012;90:e381–e388.
7. Jonas JB, Tao Y, Neumaier M, Findeisen P. Monocyte chemoattractant protein 1, intercellular adhesion molecule 1, and vascular cell adhesion molecule 1 in exudative age-related macular degeneration. Arch Ophthalmol. 2010;128:1281–1286.
8. Jonas JB, Neumaier M. Vascular endothelial growth factor and basic fibroblast growth factor in exudative age-related macular degeneration and diffuse diabetic macular edema. Ophthalmic Res. 2007;39:139–142.
9. Jo N, Mailhos C, Ju M, et al. Inhibition of platelet-derived growth factor B signaling enhances the efficacy of anti-vascular endothelial growth factor therapy in multiple models of ocular neovascularization. Am J Pathol. 2006;168:2036–2053.
10. Jonas JB, Neumaier M. Erythropoietin levels in aqueous humour in eyes with exudative age-related macular degeneration and diabetic retinopathy. Clin Experiment Ophthalmol. 2007;35:186–187.
11. Kramer M, Hasanreisoglu M, Feldman A, et al. Monocyte chemoattractant protein-1 in the aqueous humour of patients with age-related macular degeneration. Clin Experiment Ophthalmol. 2012;40:617–625.
12. Wilkinson-Berka JL, Wraight C, Werther G. The role of growth hormone, insulin-like growth factor and somatostatin in diabetic retinopathy. Curr Med Chem. 2006;13:3307–3317.
13. Spraul CW, Baldysiak-Figiel A, Lang GK, Lang GE. Octreotide inhibits growth factor-induced bovine choriocapillary endothelial cells in vitro. Graefes Arch Clin Exp Ophthalmol. 2002; 240:227–231.
14. Rosenthal R, Wohlleben H, Malek G, et al. Insulin-like growth factor-1 contributes to neovascularization in age-related macular degeneration. Biochem Biophys Res Commun. 2004;323:1203–1208.
15. Feldman EL, Randolph AE. Regulation of insulin-like growth factor binding protein synthesis and secretion in human retinal pigment epithelial cells. J Cell Physiol. 1994;158:198–204.
16. Azar WJ, Azar SH, Higgins S, et al. IGFBP-2 enhances VEGF gene promoter activity and consequent promotion of angiogenesis by neuroblastoma cells. Endocrinology. 2011;152: 3332–3342.
17. Muether PS, Hermann MM, Viebahn U, Kirchhof B, Fauser S. Vascular endothelial growth factor in patients with exudative age-related macular degeneration treated with ranibizumab. Ophthalmology. 2012;119:2082–2086.
18. Tong JP, Chan WM, Liu DT, et al. Aqueous humor levels of vascular endothelial growth factor and pigment epitheliumderived factor in polypoidal choroidal vasculopathy and choroidal neovascularization. Am J Ophthalmol. 2006;141: 456–462.
19. Funk M, Karl D, Georgopoulos M, et al. Neovascular agerelated macular degeneration: intraocular cytokines and growth factors and the influence of therapy with ranibizumab. Ophthalmology. 2009;116:2393–2399.
20. Roh MI, Lim SJ, Ahn JM, Lim JB, Kwon OW. Concentration of cytokines in age-related macular degeneration after consecutive intravitreal bevacizumab injection. Graefes Arch Clin Exp Ophthalmol. 2010;248:635–640.
21. CATT Research Group, Martin DF, Maguire MG, et al. Ranibizumab and bevacizumab for neovascular age-related macular degeneration. N Engl J Med. 2011;364:1897–1908.
22. Kim TW, Kang JW, Ahn J, et al. Proteomic analysis of the aqueous humor in age-related macular degeneration (AMD) patients. J Proteome Res. 2012;11:4034–4043.
23. Sung HJ, Han JI, Lee JW, Uhm KB, Heo K. TCCR/WSX-1 is a novel angiogenic factor in age-related macular degeneration. Mol Vis. 2012;18:234–240.
24. Clemmons DR, Jones JI, Busby WH, Wright G. Role of insulinlike growth factor binding proteins in modifying IGF actions. Ann N Y Acad Sci. 1993;692:10–21.
25. Arnold DR, Moshayedi P, Schoen TJ, Jones BE, Chader GJ, Waldbillig RJ. Distribution of IGF-I and -II, IGF binding proteins (IGFBPs) and IGFBP mRNA in ocular fluids and tissues: potential sites of synthesis of IGFBPs in aqueous and vitreous. Exp Eye Res. 1993;56:555–565.
26. Guidry C, King JL. Isolation and characterization of vitreous insulin-like growth factor binding proteins. Invest Ophthalmol Vis Sci. 2011;52:303–309.
27. Lambooij AC, van Wely KH, Lindenbergh-Kortleve DJ, Kuijpers RW, Kliffen M, Mooy CM. Insulin-like growth factor-I and its receptor in neovascular age-related macular degeneration. Invest Ophthalmol Vis Sci. 2003;44:2192–2198.
28. Shaw LC, Grant MB. Insulin like growth factor-1 and insulinlike growth factor binding proteins: their possible roles in both maintaining normal retinal vascular function and in promoting retinal pathology. Rev Endocr Metab Disord. 2004; 5:199–207.
29. Grant MB, Mames RN, Fitzgerald C, Ellis EA, Aboufriekha M, Guy J. Insulin-like growth factor I acts as an angiogenic agent in rabbit cornea and retina: comparative studies with basic fibroblast growth factor. Diabetologia. 1993;36:282–291
30. Meyer-Schwickerath R, Pfeiffer A, Blum WF, et al. Vitreous levels of the insulin-like growth factors I and II, and the insulinlike growth factor binding proteins 2 and 3, increase in neovascular eye disease. Studies in nondiabetic and diabetic subjects. J Clin Invest. 1993;92:2620–2625.
31. Höflich A, Lahm H, Blum W, Kolb H, Wolf E. Insulin-like growth factor-binding protein-2 inhibits proliferation of human embryonic kidney fibroblasts and of IGF-responsive colon carcinoma cell lines. FEBS Lett. 1998;434:329–334.
32. Hoeflich A, Nedbal S, Blum WF, et al. Growth inhibition in giant growth hormone transgenic mice by overexpression of insulin-like growth factor-binding protein-2. Endocrinology. 2001;142:1889–1898.
33. Mukherjee S, Guidry C. The insulin-like growth factor system modulates retinal pigment epithelial cell tractional force generation. Invest Ophthalmol Vis Sci. 2007;48:1892–1899.
34. Firth SM, Baxter RC. Cellular actions of the insulin-like growth factor binding proteins. Endocr Rev. 2002;23:824–854.
35. Badinga L, Song S, Simmen RC, Clarke JB, Clemmons DR, Simmen FA. Complex mediation of uterine endometrial epithelial cell growth by insulin-like growth factor-II (IGF-II) and IGF-binding protein-2. J Mol Endocrinol. 1999;23:277–285.
36. Slootweg MC, Ohlsson C, Salles JP, de Vries CP, Netelenbos JC. Insulin-like growth factor binding proteins-2 and -3 stimulate growth hormone receptor binding and mitogenesis in rat osteosarcoma cells. Endocrinology. 1995;136:4210–4217.
37. Sprenger CC, Damon SE, Hwa V, Rosenfeld RG, Plymate SR. Insulin-like growth factor binding protein-related protein 1 (IGFBP-rP1) is a potential tumor suppressor protein for prostate cancer. Cancer Res. 1999;59:2370–2375.
38. Sun T, Cao H, Xu L, Zhu B, Gu Q, Xu X. Insulin-like growth factor binding protein-related protein 1 mediates VEGFinduced proliferation, migration and tube formation of retinal endothelial cells. Curr Eye Res. 2011;36:341–349.
39. Simó R, Carrasco E, García-Ramírez M, Hernández C. Angiogenic and antiangiogenic factors in proliferative diabetic retinopathy. Curr Diabetes Rev. 2006;2:71–98.
40. Nocentini G, Ronchetti S, Petrillo MG, Riccardi C. Pharmacological modulation of GITRL/GITR system: therapeutic perspectives. Br J Pharmacol. 2012;165:2089–2099.
41. Kim BJ, Li Z, Fariss RN, et al. Constitutive and cytokineinduced GITR ligand expression on human retinal pigment epithelium and photoreceptors. Invest Ophthalmol Vis Sci. 2004;45:3170–3176.
42. Telander DG. Inflammation and age-related macular degeneration (AMD). Semin Ophthalmol. 2011;26:192–197.